ctrl K

Elevai Labs Inc. Common S... (ELAB)

NASDAQ: ELAB · Real-Time Price · USD

2.65

0.26 (10.88%)

At close: May 02, 2025, 1:47 PM

Elevai Labs Common Stock Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	1.71M	766.28K	827.00	n/a
Cost of Revenue	n/a	578.01K	324K	2.85K	n/a
Gross Profit	n/a	1.13M	442.27K	-2.02K	n/a
Operating Income	-4.02M	-3.67M	-1.79M	-785.06K	-221.84K
Interest Income	12.89K	5.56K	7.7K	n/a	n/a
Pretax Income	n/a	-4.3M	-1.8M	-784.74K	-222.91K
Net Income	n/a	-4.3M	-1.8M	-784.74K	-222.91K
Selling & General & Admin	855.76K	4.03M	1.8M	633.96K	102.99K
Research & Development	104.65K	426.24K	228.75K	123.63K	118.86K
Other Expenses	2.7M	-3.32M	-198.44K	-25.45K	n/a
Operating Expenses	3.66M	1.13M	2.23M	783.04K	222.91K
Interest Expense	-735.2K	19.52K	2.63K	n/a	n/a
Selling & Marketing Expenses	292.52K	660.29K	192.86K	31.61K	6.08K
Cost & Expenses	n/a	5.47M	2.55M	785.89K	222.91K
Income Tax Expense	n/a	n/a	-2	3.00	-1.07K
Shares Outstanding (Basic)	7.96M	10.75M	9.53M	9.46M	4.41M
Shares Outstanding (Diluted)	7.96M	10.75M	9.53M	9.46M	4.41M
EPS (Basic)	n/a	-0.4	-0.19	-0.08	-0.05
EPS (Diluted)	n/a	-0.4	-0.19	-0.08	-0.05
EBITDA	-4.02M	-4.27M	-1.78M	-782.3K	-1.07K
EBIT	n/a	-4.28M	-1.8M	-784.74K	n/a
Depreciation & Amortization	n/a	11.65K	6.51K	2.76K	221.84K